GCP
PACB icon

GSA Capital Partners’s Pacific Biosciences PACB Stock Holding History

GSA Capital Partners’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-137,332
Closed -$181K – 2057
2026
Q1 		$181K Sell
137,332
-167,845
-55% -$300K 0.01% 1478
2025
Q4 		$571K Sell
305,177
-104,193
-25% -$200K 0.05% 719
2025
Q3 		$524K Buy
+409,370
New +$554K 0.04% 816
2025
Q2 		– Sell
-208,776
Closed -$246K – 2044
2025
Q1 		$246K Buy
+208,776
New +$320K 0.02% 1277
2024
Q3 		– Sell
-595,874
Closed -$816K – 1906
2024
Q2 		$816K Buy
+595,874
New +$1.2M 0.06% 648
2020
Q2 		– Sell
-132,076
Closed -$404K – 976
2020
Q1 		$404K Buy
+132,076
New +$541K 0.1% 278
2019
Q2 		– Sell
-49,403
Closed -$357K – 1663
2019
Q1 		$357K Buy
+49,403
New +$357K 0.04% 894
2016
Q3 		– Sell
-41,800
Closed -$294K – 1907
2016
Q2 		$294K Buy
41,800
+19,384
+86% +$177K 0.02% 1393
2016
Q1 		$191K Buy
22,416
+10,505
+88% +$103K 0.01% 1503
2015
Q4 		$156K Buy
+11,911
New +$107K 0.01% 1689
2015
Q3 		– Sell
-176,294
Closed -$1.01M – 1959
2015
Q2 		$1.01M Buy
176,294
+37,311
+27% +$216K 0.04% 887
2015
Q1 		$812K Buy
138,983
+107,367
+340% +$740K 0.03% 1036
2014
Q4 		$248K Sell
31,616
-32,044
-50% -$205K 0.02% 1370
2014
Q3 		$313K Buy
+63,660
New +$333K 0.02% 1235

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

GSA Capital Partners's PACB Position: Q2 2026 in Review

GSA Capital Partners sold out of Pacific Biosciences (PACB) in Q2 2026, closing a stake of 137,332 shares — an estimated $181K sold.

GSA Capital Partners first reported a position in PACB in Q3 2014 and held it in 14 quarters. The position peaked at $1.01M in Q2 2015. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • GSA Capital Partners reported no remaining Pacific Biosciences position as of Q2 2026 after selling out during the quarter.
  • GSA Capital Partners sold 137,332 Pacific Biosciences shares in Q2 2026, an estimated $181K.
  • GSA Capital Partners first reported a position in Pacific Biosciences in Q3 2014 and held it in 14 quarters.
  • GSA Capital Partners's Pacific Biosciences position peaked at $1.01M in Q2 2015.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.